Daniel M. Harrison

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis

Daniel M. Harrison, Snehashis Roy, Jiwon Oh et al. · JAMA Neurology · 2015 · 195 citations · Full text

Medicine, Neurology, Neuroscience +14

Progressive multifocal leukoencephalopathy in transplant recipients

Farrah J. Mateen, Rajanandini Muralidharan, Marco Carone et al. · Annals of Neurology · 2011 · 181 citations

Medicine, Immunology, Neurology +13

OH and HO2 radical chemistry in a forested region of north-western Greece

Nicola Carslaw, D. J. Creasey, Daniel M. Harrison et al. · Atmospheric Environment · 2001 · 159 citations

Natural Sciences, Chemistry, Forestry +16

COVID-19 mRNA vaccination leading to CNS inflammation: a case series

Mahsa Khayat-Khoei, Shamik Bhattacharyya, Joshua Katz et al. · Journal of Neurology · 2021 · 133 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16